Panacea Life Sciences Holdings, Inc. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Panacea Life Sciences Holdings, Inc. (PLSH) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $0 as of 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2021-05-27
- 2021-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2020-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2020-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net -$33.98K.
- 2020-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net -$234.26K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-27 |
| 2020-12-31 | $0.00 10-Q/A · filed 2021-05-27 |
| 2020-09-30 | -$33.98K 10-Q · filed 2020-11-18 |
| 2020-06-30 | -$234.26K 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$515.07K 10-Q · filed 2020-06-29 |
| 2019-12-31 | -$755.71K 10-K/A · filed 2021-04-23 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-20 |
| 2018-12-31 | -$109.91K 10-K · filed 2020-05-22 |
| 2018-09-30 | -$92.74K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$172.56K 10-Q · filed 2018-08-20 |
| 2018-03-31 | -$241.07K 10-Q · filed 2018-05-21 |
| 2017-12-31 | -$274.70K 10-K · filed 2019-03-29 |
| 2017-09-30 | -$123.49K 10-Q · filed 2017-11-20 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |